BPC 157 TB 500 Blend Xcel Peptides NOVO NORDISK, INC., Plaintiff, v. WELLS PHARMACY NETWORK, LLC, Defendant. Case No.: 5:23 cv 00689 ACC PRL ORDER This cause come The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and ARENIS MEDICO BPC 157 + TB 500